Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Greenberg

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Scandinavian Journal of Haematology|November 1, 1980
Clinical relevance of in vitro study of granulocytopoiesisP L Greenberg
Blood Cells|January 1, 1991
Effects of insulin-like growth factors on hemopoiesisP L Greenberg
Seminars in Oncology|February 1, 1992
Treatment of myelodysplastic syndromes with hemopoietic growth factorsP L Greenberg
Clinics in Haematology|November 1, 1986
In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disordersP L Greenberg
Seminars in Oncology|February 1, 1992
In vitro marrow culture studies in the myelodysplastic syndromesP L Greenberg
Leukemia Research|September 12, 1998
Risk factors and their relationship to prognosis in myelodysplastic syndromesP L Greenberg
Leukemia Research|January 28, 1999
Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatmentP L Greenberg
Blood Reviews|March 1, 1991
Treatment of myelodysplastic syndromesP L Greenberg
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1986
Biologic abnormalities in the myelodysplastic syndromes and myeloproliferative disordersP L Greenberg
Seminars in Hematology|October 1, 1993
Use of recombinant human erythropoietin to treat the anemia of myelodysplastic syndromesP L Greenberg
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Scandinavian Journal of Haematology|November 1, 1980
Clinical relevance of in vitro study of granulocytopoiesisP L Greenberg
Blood Cells|January 1, 1991
Effects of insulin-like growth factors on hemopoiesisP L Greenberg
Seminars in Oncology|February 1, 1992
Treatment of myelodysplastic syndromes with hemopoietic growth factorsP L Greenberg
Clinics in Haematology|November 1, 1986
In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disordersP L Greenberg
Seminars in Oncology|February 1, 1992
In vitro marrow culture studies in the myelodysplastic syndromesP L Greenberg
Leukemia Research|September 12, 1998
Risk factors and their relationship to prognosis in myelodysplastic syndromesP L Greenberg
Leukemia Research|January 28, 1999
Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatmentP L Greenberg
Blood Reviews|March 1, 1991
Treatment of myelodysplastic syndromesP L Greenberg
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1986
Biologic abnormalities in the myelodysplastic syndromes and myeloproliferative disordersP L Greenberg
Seminars in Hematology|October 1, 1993
Use of recombinant human erythropoietin to treat the anemia of myelodysplastic syndromesP L Greenberg
Pageof 8